Althea Technologies Overview

  • Founded
  • 1998

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 220

Employees
  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $175M

  • Investors
  • 1

Althea Technologies General Information

Description

Provider of contract manufacturing services to the pharmaceutical and biotechnology industries. The company provides gene expression analysis using eXpress Profiling technology and quantitative PCR testing services. It offers cGMP drug product filling in both vials and syringes, and production of microbial-derived recombinant proteins and plasmid DNA.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • 11040 Roselle Street
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Althea Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 04-Apr-2013 $175M 000.00 00000 Completed Generating Revenue
7. Debt - General 31-Dec-2010 0000 000.00 Completed Generating Revenue
6. Mezzanine 03-Aug-2010 000.00 000.00 Completed Generating Revenue
5. Debt - General 16-Sep-2008 000.00 Completed
4. Later Stage VC (Series C) 09-Jan-2007 0000 000.00 Completed Generating Revenue
3. Debt - General 19-Jun-2002 00.00 00.00 Completed Generating Revenue
2. Early Stage VC (Series B) Completed
1. Early Stage VC (Series A) Completed
To view Althea Technologies’s complete valuation and funding history, request access »

Althea Technologies Patents

Althea Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2271750-A1 Uricase compositions and methods of use Inactive 24-Mar-2008 000000000
EP-2271750-A4 Uricase compositions and methods of use Inactive 24-Mar-2008 000000000
US-20110171268-A1 Uricase compositions and methods of use Inactive 24-Mar-2008 000000000
EP-2486916-A8 Human growth hormone formulations Active 18-Dec-2006 0000000000
US-8071544-B2 Crystallized recombinant human growth factor formulations Active 18-Dec-2006 A61K9/0019
To view Althea Technologies’s complete patent history, request access »

Althea Technologies Executive Team (12)

Name Title Board Seat Contact Info
E.J. Brandreth Senior Vice President of Quality and Regulatory
Jack Wright Vice President of Sales & Marketing
Magda Marquet Ph.D President & Chief Executive Officer
You’re viewing 3 of 12 executive team members. Get the full list »

Althea Technologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Althea Technologies Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
NuFund Angel Group Minority 000 0000 000000 0
Telegraph Hill Partners Venture Capital Minority 000 0000 000000 0
To view Althea Technologies’s complete investors history, request access »

Althea Technologies Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000 04-May-2010 0000000000 Biotechnology
To view Althea Technologies’s complete acquisitions history, request access »